AzTrials
AzTrials

Gastric Emptying TimeNCT05244902

Gastric Emptying Times of Normal and Obese Children After Preoperative Clear Fluid Drinking: An Ultrasound Study

A study testing 5% Dextrose in people with Gastric Emptying Time, run by Karaman Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In the recent literature, pre-operative fasting times for pediatric patients are limited to one hour for clear fluids. Studies related to gastric emptying times mostly searched for normal-weight children. These studies have claimed that 3 mL/kg clear fluid can be allowed up to 1 hour before surgery. Read more about this study

Who is it for?
Ages 6 to 14 years
Conditions the study is for
Gastric Emptying Time
What is being tested?
5% Dextrose
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Mar 2022to 17 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • ASA physical state I or II
  • Age 6 to 14 years.
  • Gender: both sexes.
  • Scheduled for non-Gastrointestinal Tract elective day-case surgery under general anesthesia.

Who cannot join

  • Parent/ care giver refusal
  • Ages < 6 or > 14 years old
  • Children with gastro-esophageal reflux disease
  • Renal failure
  • Diabetes mellitus
  • Cerebral palsy patients
Show all 12Show fewer
  • Mental retardation
  • Esophageal strictures, achalasia or any intestinal disease that may impair the gastric emptying.
  • Gastrointestinal system surgery and neurosurgical patients
  • Emergency surgery
  • Violation of the prescribed fasting times
  • Refusing to drink prescribed clear fluid

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Karaman Taining and Research Hospital

    Karaman, 70200

Other trials in Turkey (Türkiye)

About this study

In the recent literature, pre-operative fasting times for pediatric patients are limited to one hour for clear fluids. Studies related to gastric emptying times mostly searched for normal-weight children. These studies have claimed that 3 mL/kg clear fluid can be allowed up to 1 hour before surgery. There is a lack of interest in the gastric emptying time of obese pediatric patients during the preoperative period. In addition, there is controversy about gastric emptying times of obese healthy children. Some research committed the decrease of gastric emptying because of a high level of sensitivity to cholecystokinin, while others postulated that no change in gastric emptying time of obese children compared to normal weight. The aim of this trial is to compare the gastric volume and gastric emptying time after ingestion of 3 mL/kg clear fluid in obese and non-obese pediatric patients in the pre-operative period.

Read the detailed description

After receiving informed consent from the children and their families, American Society of Anesthesiologists (ASA) 1-2 pediatric patients between 6-14 years, who will recruit for elective surgery will be included for this study. The children over 95% percentile will be accepted as obese. After, the basal gastric volume will be calculated with the help of Ultrasonography (USG). The children will receive oral 3 mL/kg(max 250 mL) 5% dextrose .USG evaluation will be made every 5 minutes until the gastric volume reaches the basal level. Children reaching basal gastric volume will be accepted as suitable for the surgery. The aim of this study is to compare the gastric volume and gastric emptying time after ingestion of 3 mL/kg clear fluid in obese and non-obese pediatric patients in the pre-operative period.

Being tested
5% Dextrose
Keywords
Gastric volume, Gastric emptying time, Antral cross-sectional area (ACSA), Obese pediatric patients

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 5% DextroseDrug

    All the patients will receive oral 3mL/kg 5%Dextrose

Study groups in NCT05244902
Study groupRoleWhat they receive
Obese pediatric patientExperimentalObese children aged 6-14 years, over 95% percentile, fasted for the night before planned surgery.
Receives: Drug: 5% Dextrose
Non-obese pediatric patientActive comparatorNon-obese children aged 6-14 years, between 5-85% percentile, fasted for the night before planned surgery.
Receives: Drug: 5% Dextrose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gastric emptying time

    Time until the gastric volume reaches the baseline level again.

    Measured: 90 minute

Secondary outcomes (1)
  1. Antral cross-sectional area

    Antral cross-Section Area (ACSA) (cm2) maximal anteroposterior diameter (D1) and longitudinal diameter (D2) will be measured with ultrasound and calculated with that mathematical formula:

    ACSA(cm2) = Π x D1 x D2 / 4

    Measured: 90 minute

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2022
  2. Study start10 Mar 2022
  3. Primary completion17 Aug 2022
  4. Study completion17 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Pediatric patients will be divided into two groups as obese and non-obese. Children above the 95% percentile will be considered as obese.
Masking
None (open label)
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05244902
Sponsor's protocol ID
08-2021/12
Status last verified
Nov 2022
First submitted
8 Feb 2022
Last updated
25 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing 5% Dextrose in people with Gastric Emptying Time, run by Karaman Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gastric emptying time (time frame: 90 minute). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in